10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Clinical trial NCT05890963 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05890963
Sponsor: David Ho
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2023-11-28
Primary completion: 2026-04-14
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.